This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Suzhou Alphamab Co., Ltd., Xin Zhang, Xitian Zhang. Active years: 2021-2024.
Company Filing History:
2 out of 8 
2 out of 2 
2 out of 2 Years Active: 2021-2024
Title: Qian Chu - Innovator in Medical Biology
Introduction
Qian Chu is a notable inventor based in Suzhou, China. He has made significant contributions to the field of medical biology, particularly in the development of innovative therapeutic proteins. With a total of 2 patents, his work focuses on addressing critical health challenges.
Latest Patents
Qian Chu's latest patents include a single domain antibody and derivative proteins against CTLA4. This invention relates to the medical biology field and discloses a CTLA4 binding protein. The use of this protein is particularly aimed at treating and preventing CTLA4 relevant diseases, such as tumors. His research is pivotal in advancing therapeutic options for patients suffering from these conditions.
Career Highlights
Throughout his career, Qian has worked with prominent companies, including Suzhou Alphamab Co., Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in medical biology.
Collaborations
Qian has collaborated with talented individuals in his field, including Ting Xu and Xiaoxiao Wang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Qian Chu's contributions to medical biology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treatments for serious health conditions.